Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-09-29

FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Jubilant Cadista's supplemental application for Losartan potassium and hydrochlorothiazide, a generic combination product used to treat hyperte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan potassium and hydrochlorothiazide (losartan potassium and hydrochlorothiazide)

Snippet

SUPPL AP for LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE)